You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

GENTAFAIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Gentafair patents expire, and when can generic versions of Gentafair launch?

Gentafair is a drug marketed by Pharmafair and is included in five NDAs.

The generic ingredient in GENTAFAIR is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Gentafair

A generic version of GENTAFAIR was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for GENTAFAIR?
  • What are the global sales for GENTAFAIR?
  • What is Average Wholesale Price for GENTAFAIR?
Summary for GENTAFAIR
US Patents:0
Applicants:1
NDAs:5
Raw Ingredient (Bulk) Api Vendors: 34
DailyMed Link:GENTAFAIR at DailyMed
Drug patent expirations by year for GENTAFAIR

US Patents and Regulatory Information for GENTAFAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair GENTAFAIR gentamicin sulfate CREAM;TOPICAL 062458-001 Sep 1, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmafair GENTAFAIR gentamicin sulfate OINTMENT;TOPICAL 062444-001 May 26, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmafair GENTAFAIR gentamicin sulfate INJECTABLE;INJECTION 062493-001 Aug 28, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pharmafair GENTAFAIR gentamicin sulfate OINTMENT;OPHTHALMIC 062443-001 May 26, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.